These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16089166)

  • 21. Experience with validation of clinical trial materials: an inspector's viewpoint.
    Wolfe L
    Dev Biol (Basel); 2003; 113():27-33. PubMed ID: 14620849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which pharmacovigilance for vaccines?
    Le Louët H; Loupi E; Haramburu F;
    Therapie; 2007; 62(3):241-7. PubMed ID: 17803893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Requirements on the production and testing of sera and vaccines].
    Bonin O
    Fortschr Med; 1977 Jun; 95(23):1541-8. PubMed ID: 881153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of risk assessment to veterinary biologicals: the perspective of the animal health industry.
    Folkers C; Draayer HA; Verschueren C
    Rev Sci Tech; 1995 Dec; 14(4):1207-16. PubMed ID: 8639957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WHO activities to assure the quality of biological products.
    Magrath D
    Dev Biol Stand; 1993; 81():265-8. PubMed ID: 8174812
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
    Simek SL
    Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary: standardization and quality control in state-sponsored biologicals production.
    Spaander J
    Bull World Health Organ; 1977; 55 Suppl 2(Suppl 2):41-4. PubMed ID: 305314
    [No Abstract]   [Full Text] [Related]  

  • 28. Bad medicine.
    Sheridan C
    Nat Biotechnol; 2007 Jul; 25(7):707-9. PubMed ID: 17621284
    [No Abstract]   [Full Text] [Related]  

  • 29. Biosimilar somatropin: myths and facts.
    Hoppe W; Berghout A
    Horm Res; 2008; 69(1):29-30. PubMed ID: 18057914
    [No Abstract]   [Full Text] [Related]  

  • 30. WHO Expert Committee on biological standardization.
    World Health Organ Tech Rep Ser; 2007; (941):1-340, back cover. PubMed ID: 18314862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in natural health product research: The importance of standardization.
    Shan JJ; Rodgers K; Lai CT; Sutherland SK
    Proc West Pharmacol Soc; 2007; 50():24-30. PubMed ID: 18605225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The production of veterinary preparations and control of their quality].
    Deshkevich DK
    Veterinariia; 1968 Jul; 45(7):61-2. PubMed ID: 5736461
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sterility control in drugs of biological origin].
    Kindt H; Körner L
    Arzneimittelforschung; 1969 Feb; 19(2):208-13. PubMed ID: 5818760
    [No Abstract]   [Full Text] [Related]  

  • 34. Commentary: the role of the International Association of Biological Standardization.
    Hennessen W
    Bull World Health Organ; 1977; 55 Suppl 2(Suppl 2):155-6. PubMed ID: 305307
    [No Abstract]   [Full Text] [Related]  

  • 35. Seventh WHO informal consultation on standards for cytokines, growth factors and endocrinological substances.
    Meager A
    Biologicals; 2004 Jun; 32(2):105-11. PubMed ID: 15454189
    [No Abstract]   [Full Text] [Related]  

  • 36. [Official experimental testing of biomedical products. Regulatory frame and importance of for quality, safety and efficacy].
    Vieths S; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1133-8. PubMed ID: 25123139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bills target biosimilar drugs.
    Wadman M
    Nature; 2009 Mar; 458(7237):394-5. PubMed ID: 19325595
    [No Abstract]   [Full Text] [Related]  

  • 38. Biotechs go generic: the same but different.
    Ledford H
    Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194
    [No Abstract]   [Full Text] [Related]  

  • 39. Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
    Tremaine WJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):735-41. PubMed ID: 17129810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WHO Expert Committee on Biological Standardization. Thirtieth report.
    World Health Organ Tech Rep Ser; 1979; (638):1-199. PubMed ID: 120636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.